| Gefitinib治疗晚期细支气管肺泡癌 |
| |
| 引用本文： | Zhang XT,Wang SL,Li LY. Gefitinib治疗晚期细支气管肺泡癌[J]. 中国医学科学院学报, 2004, 26(3): 340-343 |
| |
| 作者姓名： | Zhang XT Wang SL Li LY |
| |
| 作者单位： | 中国医学科学院,中国协和医科大学,北京协和医院呼吸科,北京,100730 |
| |
| 摘 要： | 本院3例晚期重症支气管肺泡癌患者经新型靶向制剂表皮生长因子酪氨酸激酶抑制剂Gefitinib(Iressa)治疗取得显著疗效,提示Gefitinib可有效治疗晚期经含有铂类和/或泰索帝(TXT)治疗失败的细支气管肺泡癌及一般情况差、无法化疗的患者.
|
| 关 键 词： | 表皮生长因子受体 肺肿瘤 化学治疗 |
| 修稿时间： | 2003-12-02 |
Gefitinib for advanced bronchioloalveolar carcinoma |
| |
| Zhang Xiao-tong,Wang Shu-lan,Li Long-yun. Gefitinib for advanced bronchioloalveolar carcinoma[J]. Acta Academiae Medicinae Sinicae, 2004, 26(3): 340-343 |
| |
| Authors: | Zhang Xiao-tong Wang Shu-lan Li Long-yun |
| |
| Affiliation: | Department of Respiratory Disease, PUMC Hospital, CAMS and PUMC, Beijing 100730, China. |
| |
| Abstract: | We described 3 cases of advanced bronchioloalveolar carcinoma(BAC), in whom once-daily treatment with 250 mg Gefitinib(Iressa)demonstrated remarkable antitumor effects. Gefitinib may produce dramatic clinical responses when admi-nistered to patients with poor performance status who had received heavy platinum/docetaxel-based prior chemotherapy. |
| |
| Keywords: | epidermal growth factor receptor pulmonary neoplasma chemotherapy |
| 本文献已被 CNKI 维普 万方数据 PubMed 等数据库收录！ |
